Medical

Dr. David W. Brown claims Boehringer Ingelheim Pharmaceuticals owes him money for suggesting that its Mirapex drug might be used to treat people for Tourette syndrome, in Austin Federal Court.

The new use could extend Boehringer's soon-to-expire patent on the drug used for restless-leg syndrome, Brown says, and he deserves some of the $380 million a year the drug brings in if it does.

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Email *

Submit